Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 48.5156.2082.53135.57-72.44

What is the latest EBIT Growth ratio of KILITCH DRUGS (INDIA) ?

The latest EBIT Growth ratio of KILITCH DRUGS (INDIA) is 48.51 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202448.51
Mar202356.20
Mar202282.53
Mar2021135.57
Mar2020-72.44

How is EBIT Growth of KILITCH DRUGS (INDIA) Trending?

Years EBIT Growth % Change
Mar2024 48.51
-13.68
Mar2023 56.2
-31.90
Mar2022 82.53
-39.12
Mar2021 135.57
Positive
Mar2020 -72.44 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare EBIT Growth ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹622.3 Cr -8.3% -20.2% 1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹375,388.0 Cr -5.6% -9.9% -12.1% Stock Analytics
DIVIS LABORATORIES ₹162,513.0 Cr -2.5% -8.4% 21.7% Stock Analytics
CIPLA ₹126,733.0 Cr -0.8% 1.8% -1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,292.0 Cr -2.4% -4% 4.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,935.0 Cr -0.3% -0.9% -9.7% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-8.3%

-20.2%

1.9%

SENSEX

-1.2%

-1.2%

-1.7%


You may also like the below Video Courses